All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Silicon Valley's longevity movement confronts scientific limits as Bryan Johnson halts Rapamycin use

By

Skye Jacobs

8d ago· 7 min readenInsight

Summary

Silicon Valley's longevity movement is facing a reality check as key figures confront the limits of anti-aging science. Bryan Johnson stopped taking Rapamycin in September 2024 after years of self-experimentation, signaling a broader retreat from the hype surrounding longevity drugs. The article examines how the movement's promises have yet to be substantiated by rigorous science, and how even its most devoted proponents are beginning to acknowledge the gap between ambition and evidence.

Source

Twitter / XSilicon Valley's longevity movement confronts scientific limits as Bryan Johnson halts Rapamycin usetechspot.com

Key quotes

· 3 pulled
The most revealing development in Silicon Valley's longevity movement is not a new compound or breakthrough protocol, but a retreat.
Bryan Johnson, the tech entrepreneur who turned his body into a public experiment, stopped taking Rapamycin in September 2024 after several years of self-testing the drug.
That shift comes as some of the movement's most prominent figures begin confronting the limits of a science that has yet to live up to the hype.
Snippet from the RSS feed
Bryan Johnson, the tech entrepreneur who turned his body into a public experiment, stopped taking Rapamycin in September 2024 after several years of self-testing the drug. The...

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.